Article info
Hepatology
Original article
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
- Correspondence to Professor Hermona Soreq, The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190401, Israel; hermona.soreq{at}mail.huji.ac.il
Citation
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
Publication history
- Received August 12, 2016
- Revised March 16, 2017
- Accepted March 18, 2017
- First published April 5, 2017.
Online issue publication
August 06, 2018
Article Versions
- Previous version (6 August 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/